JFS Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.2K | Sell |
118
-5
| -4% | -$438 | ﹤0.01% | 999 |
|
|
2026
Q1 | $11.1K | Sell |
123
-25
| -17% | -$2.29K | ﹤0.01% | 911 |
|
|
2025
Q4 | $13.3K | Sell |
148
-279
| -65% | -$26.5K | ﹤0.01% | 879 |
|
|
2025
Q3 | $42.1K | Buy |
427
+322
| +307% | +$31.9K | ﹤0.01% | 535 |
|
|
2025
Q2 | $9.58K | Sell |
105
-42
| -29% | -$4.06K | ﹤0.01% | 878 |
|
|
2025
Q1 | $16.6K | Sell |
147
-31
| -17% | -$3.32K | ﹤0.01% | 718 |
|
|
2024
Q4 | $18.8K | Buy |
178
+32
| +22% | +$3.43K | ﹤0.01% | 663 |
|
|
2024
Q3 | $15.8K | Sell |
146
-15
| -9% | -$1.64K | ﹤0.01% | 698 |
|
|
2024
Q2 | $17.5K | Buy |
161
+10
| +7% | +$1.18K | ﹤0.01% | 631 |
|
|
2024
Q1 | $19.9K | Buy |
151
+6
| +4% | +$749 | ﹤0.01% | 623 |
|
|
2023
Q4 | $17.6K | Sell |
145
-8
| -5% | -$893 | ﹤0.01% | 613 |
|
|
2023
Q3 | $17.2K | Sell |
153
-12
| -7% | -$1.52K | ﹤0.01% | 583 |
|
|
2023
Q2 | $24K | Hold |
165
| – | – | ﹤0.01% | 501 |
|
|
2023
Q1 | $21.3K | Buy |
165
+1
| +0.6% | +$126 | ﹤0.01% | 523 |
|
|
2022
Q4 | $20.9K | Buy |
164
+12
| +8% | +$1.39K | ﹤0.01% | 526 |
|
|
2022
Q3 | $16K | Sell |
152
-39
| -20% | -$4.28K | ﹤0.01% | 625 |
|
|
2022
Q2 | $20K | Buy |
191
+26
| +16% | +$3.08K | ﹤0.01% | 591 |
|
|
2022
Q1 | $21K | Buy |
165
+130
| +371% | +$15.7K | ﹤0.01% | 602 |
|
|
2021
Q4 | $4K | Buy |
35
+25
| +250% | +$3.27K | ﹤0.01% | 897 |
|
|
2021
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 822 |
|
|
2021
Q2 | $2K | Sell |
10
-21
| -68% | -$3.4K | ﹤0.01% | 563 |
|
|
2021
Q1 | $5K | Hold |
31
| – | – | ﹤0.01% | 471 |
|
|
2020
Q4 | $5K | Hold |
31
| – | – | ﹤0.01% | 479 |
|
|
2020
Q3 | $4K | Buy |
31
+21
| +210% | +$2.74K | ﹤0.01% | 473 |
|
|
2020
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 520 |
|
|
2020
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 495 |
|
|
2019
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 500 |
|
|
2019
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 506 |
|
|
2019
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 451 |
|
|
2019
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 452 |
|
|
2018
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 439 |
|
|
2018
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 512 |
|
|
2018
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 446 |
|
|
2018
Q1 | $1K | Sell |
10
-103
| -91% | -$12K | ﹤0.01% | 509 |
|
|
2017
Q4 | $13K | Buy |
113
+103
| +1,030% | +$11.6K | ﹤0.01% | 368 |
|
|
2017
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 433 |
|
|
2017
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 407 |
|
|
2017
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 428 |
|
|
2016
Q4 | $1K | Sell |
10
-62
| -86% | -$6.64K | ﹤0.01% | 428 |
|
|
2016
Q3 | $9K | Hold |
72
| – | – | ﹤0.01% | 395 |
|
|
2016
Q2 | $8K | Hold |
72
| – | – | ﹤0.01% | 407 |
|
|
2016
Q1 | $7K | Hold |
72
| – | – | ﹤0.01% | 433 |
|
|
2015
Q4 | $7K | Hold |
72
| – | – | ﹤0.01% | 435 |
|
|
2015
Q3 | $7K | Sell |
72
-104
| -59% | -$10.4K | ﹤0.01% | 378 |
|
|
2015
Q2 | $19K | Buy |
176
+17
| +11% | +$1.88K | 0.01% | 289 |
|
|
2015
Q1 | $18K | Buy |
159
+24
| +18% | +$2.74K | 0.01% | 298 |
|
|
2014
Q4 | $15K | Hold |
135
| – | – | ﹤0.01% | 327 |
|
|
2014
Q3 | $13K | Buy |
135
+63
| +88% | +$6.2K | ﹤0.01% | 312 |
|
|
2014
Q2 | $7K | Buy |
+72
| New | +$7.03K | ﹤0.01% | 357 |
|
Other funds holding ZBH
JFS Wealth Advisors's ZBH Position: Q2 2026 in Review
JFS Wealth Advisors reduced its Zimmer Biomet (ZBH) stake by 4.1% in Q2 2026, selling an estimated $438 and leaving 118 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #999.
JFS Wealth Advisors first reported a position in ZBH in Q2 2014 and has held it in 49 quarters since. The position peaked at $42.1K in Q3 2025. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- JFS Wealth Advisors held 118 shares of Zimmer Biomet worth $10.2K as of Q2 2026.
- JFS Wealth Advisors sold 5 Zimmer Biomet shares in Q2 2026, an estimated $438.
- Zimmer Biomet made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #999 holding.
- JFS Wealth Advisors first reported a position in Zimmer Biomet in Q2 2014 and has held it in 49 quarters since.
- JFS Wealth Advisors's Zimmer Biomet position peaked at $42.1K in Q3 2025.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.